CD5L constraints acute and systemic inflammation and can be a novel potent therapeutic agent against sepsis
L. Oliveira, A. P. Gomes, R. F. Santos, M. S. Cardoso, A. Novoa, H. Luche, F. Gärtner, B. M. Malissen, M. Mallo, A. M. Carmo
This paper demonstrates that CD5L reduces sepsis severity by both anti-bacterial and anti-inflammatory mechanisms, showing therapeutic potential in mouse models.
bioRxiv · Mar 8, 2022 · PreprintImmunology